Literature DB >> 27450713

The natural history of chronic pancreatitis after operative intervention: The need for revisional operation.

Vikrom K Dhar1, Nick C Levinsky1, Brent T Xia1, Daniel E Abbott1, Gregory C Wilson1, Jeffrey J Sussman1, Milton T Smith2, Sampath Poreddy2, Kyuran Choe3, Dennis J Hanseman1, Michael J Edwards1, Syed A Ahmad4.   

Abstract

BACKGROUND: For patients with chronic pancreatitis, duodenum-sparing head resections and pancreaticoduodenectomy are effective operations to relieve abdominal pain. For patients who develop recurrent symptoms after their index operation, the long-term management remains controversial.
METHODS: Between 2002 and 2014, patients undergoing operative intervention for chronic pancreatitis were identified retrospectively. Patients requiring reoperation after their index operation were reviewed.
RESULTS: A total of 121 patients with chronic pancreatitis underwent an index operation. At a median time of 33 months, 85 patients underwent no further operative intervention, while 36 patients underwent reoperation. A reoperative procedure was completed with acceptable perioperative morbidity and blood loss. After a revision operation, 25% of patients became narcotic independent. Narcotic requirements decreased from 143 morphine equivalent milligrams per day (MEQ/d) to 80 MEQ/d, and 58% of patients required less than 50 MEQ/d. Insulin requirements were not increased from preoperative levels. Multivariate analysis demonstrated only narcotic requirement and exocrine insufficiency after the index operation to be predictive for the need for a revision operation.
CONCLUSION: Our data demonstrate the following: (1) A significant number of patients undergoing duodenum-sparing head resections (26%) or pancreaticoduodenectomy (29%) required reoperation for recurrent abdominal pain; and (2) a revisional operation can be effective in relieving recurrent abdominal symptoms. Patients with recurrent symptoms should be considered for additional operative intervention.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27450713     DOI: 10.1016/j.surg.2016.05.030

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  2 in total

1.  Secretin-Enhanced MRCP: How and Why-AJR Expert Panel Narrative Review.

Authors:  Jordan Swensson; Atif Zaheer; Darwin Conwell; Kumar Sandrasegaran; Riccardo Manfredi; Temel Tirkes
Journal:  AJR Am J Roentgenol       Date:  2021-03-11       Impact factor: 3.959

Review 2.  The Surgeon's Role in Treating Chronic Pancreatitis and Incidentally Discovered Pancreatic Lesions.

Authors:  Vikrom K Dhar; Brent T Xia; Syed A Ahmad
Journal:  J Gastrointest Surg       Date:  2017-08-14       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.